Financial Performance - For the nine months ended September 30, 2023, the group recorded revenue of approximately HKD 93.6 million, a decrease of 63.6% compared to HKD 257.3 million for the same period in 2022[5]. - The company reported a loss attributable to equity holders of approximately HKD 11.3 million for the nine months ended September 30, 2023, compared to a profit of HKD 6.2 million for the same period in 2022[5]. - The gross profit for the nine months ended September 30, 2023, was HKD 13.1 million, down from HKD 60.8 million in the same period of 2022, reflecting a significant decline in sales[22]. - Operating loss for the nine months ended September 30, 2023, was HKD 12.3 million, compared to an operating profit of HKD 9.3 million for the same period in 2022[22]. - The company experienced a net loss before tax of HKD 12.3 million for the nine months ended September 30, 2023, compared to a profit before tax of HKD 9.0 million in the same period of 2022[22]. - The total comprehensive loss attributable to equity holders for the nine months ended September 30, 2023, was HKD 12.3 million, compared to a total comprehensive income of HKD 5.3 million for the same period in 2022[7]. - The company reported a basic and diluted loss per share of HKD 0.76 for the nine months ended September 30, 2023, compared to earnings per share of HKD 0.42 for the same period in 2022[7]. - The company recorded a net loss of HKD 337,000 for the three months ended September 30, 2023, compared to a net gain of HKD 5,741,000 in the same period of 2022[32]. - The company reported a loss attributable to equity holders of approximately HKD 11,307,000 for the period, compared to a profit of approximately HKD 6,198,000 in the same period of 2022[47]. - The company's revenue for the nine months ended September 30, 2023, was approximately HKD 93,595,000, a decrease of about 64% compared to approximately HKD 257,337,000 for the same period in 2022[62]. - The company recorded a comprehensive loss attributable to equity holders of approximately HKD 11,307,000 for the period, compared to a profit of approximately HKD 6,198,000 for the same period in 2022[62]. - The gross profit for the period was approximately HKD 13,123,000, down about 78% from approximately HKD 60,762,000 for the nine months ended September 30, 2022[68]. Sales Performance - For the nine months ended September 30, 2023, the sales of TFT-LCD panels and modules amounted to approximately HKD 65,849,000, a decrease of about 51% compared to approximately HKD 135,210,000 for the same period in 2022[41]. - Sales of health-related products for the nine months ended September 30, 2023, were approximately HKD 14,823,000, down about 81% from approximately HKD 76,318,000 in the same period of 2022[42]. - The sales of polarizers dropped significantly from approximately HKD 35,864,000 for the nine months ended September 30, 2022, to about HKD 663,000 in the same period of 2023[41]. - Sales of optical products reached approximately HKD 3,104,000, an increase of about 426% compared to approximately HKD 590,000 in the same period of 2022, driven mainly by the growth in automotive heads-up display components[64]. - Sales of electronic advertising board products were approximately HKD 7,489,000, representing a growth of about 32% compared to approximately HKD 5,687,000 in the same period of 2022[64]. Expenses and Cost Management - General and administrative expenses decreased to approximately HKD 16,738,000, a reduction of about 14% from approximately HKD 19,494,000 in the same period of 2022[46]. - The company's distribution and selling expenses were approximately HKD 15,327,000, a decrease of about 19% from approximately HKD 18,951,000 in the same period of 2022[69]. - Research and development expenses for the nine months ended September 30, 2023, amounted to HKD 686,000, slightly down from HKD 748,000 in the same period of 2022[22]. - Financial expenses for the period included interest expenses of approximately HKD 127,000 for bank loans and HKD 119,000 for lease liabilities[47]. Corporate Governance and Compliance - The board of directors did not declare an interim dividend for the nine months ended September 30, 2023, consistent with the previous year[5]. - The company has adopted the principles and code provisions of the Corporate Governance Code as set out in the GEM Listing Rules, ensuring compliance during the reporting period[17]. - The company is evaluating the impact of new accounting standards on its performance and financial position[29]. Market and Strategic Developments - The company noted signs of stabilization and gradual recovery in the display panel market despite ongoing challenges[66]. - The company plans to continue diversifying its health-related product offerings to align with market demand driven by increased public health awareness post-pandemic[66]. - The company aims to broaden and optimize its product portfolio to mitigate adverse impacts from individual products[66]. - The company launched health products in response to increased public health awareness during the period[42]. - The company continues to face challenges due to low demand for consumer electronics amid an unstable macroeconomic environment[41]. Legal and Management Changes - There are ongoing legal proceedings related to claims made by the Securities and Futures Commission, which the company intends to actively contest[92]. - The board of directors has suspended the chairman and CEO pending the outcome of the legal proceedings, with an independent non-executive director appointed as acting chairman[96]. Investments - The fair value of financial assets measured at fair value through profit or loss amounted to approximately HKD 32,604,000 as of September 30, 2023, compared to HKD 25,201,000 as of December 31, 2022[33]. - The fair value of the investment in Mobvoi increased to approximately HKD 32,604,000 as of September 30, 2023, representing a growth of about 29% from HKD 25,201,000 as of December 31, 2022[43]. - The company recorded a fair value gain of approximately HKD 7,403,000 during the period, compared to a fair value loss of approximately HKD 12,581,000 in the same period of 2022[43]. - The company's stake in a Taiwanese private company involved in separator membranes for lithium batteries was diluted to approximately 0.96% as of September 30, 2023, down from 2% as of December 31, 2022[44]. - Mobvoi has developed and launched a series of AI-generated content products and submitted its listing application to the stock exchange in May 2023[43]. - The company did not redeem any shares during the period, nor did it purchase or sell any of its shares[52]. - The company’s investment in Mobvoi represents a holding of approximately 1.57% as of September 30, 2023[43].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Perfect Optronics Limited 圓 美 光 電 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8311） 截至二零二三年九月三十日止九個月 第三季度業績公告 香港聯合交易所有限公司（「聯交所」）GEM（「GEM」）的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所主板 上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並 應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交所主板買賣 之證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市 場。 本公告的資料乃遵照《香港聯合交易所有限公司的GEM證券上巿規則》（「GEM上市規則」） 而刊載，旨在提供有關圓美光電有限公司（「本公司」）的資料；本公司董事（「董事」）願就 ...

Financial Performance - The group reported a loss attributable to equity holders of approximately HKD 3,859,000 for the period, compared to a profit of approximately HKD 2,515,000 for the six months ended June 30, 2022[2]. - For the six months ended June 30, 2023, the company recorded revenue of approximately HKD 66.5 million, a decrease of 68.3% compared to HKD 209.9 million for the same period in 2022[49]. - The gross profit for the six months ended June 30, 2023, was HKD 10.1 million, down from HKD 52.2 million in the same period of 2022, reflecting a significant decline in sales[50]. - Operating loss for the six months ended June 30, 2023, was HKD 4.5 million, compared to an operating profit of HKD 5.6 million for the same period in 2022[50]. - The company reported a basic and diluted loss per share of HKD (0.26) for the six months ended June 30, 2023, compared to a profit of HKD 0.17 for the same period in 2022[107]. - The company recorded a consolidated loss attributable to equity holders of approximately HKD 3,859,000, compared to a profit of approximately HKD 2,515,000 for the six months ended June 30, 2022[142]. Revenue Breakdown - Revenue for the six months ended June 30, 2023, was HKD 66,500 thousand, a decrease of 68.3% compared to HKD 209,854 thousand for the same period in 2022[86]. - Revenue from the TFT-LCD segment was HKD 48,398 thousand, down 56.0% from HKD 110,067 thousand in the previous year[86]. - Revenue from health-related products dropped to HKD 11,913 thousand, a decline of 82.0% from HKD 66,191 thousand in the prior year[86]. - Revenue from electronic billboards increased to HKD 5,023 thousand, up 26.0% from HKD 3,989 thousand in the previous year[86]. - Major customer A contributed HKD 13,996 thousand in revenue, an increase of 9.7% from HKD 12,758 thousand in the same period last year[102]. Assets and Liabilities - Total assets as of June 30, 2023, amounted to HKD 144.6 million, a decrease from HKD 153.8 million as of December 31, 2022[51]. - The total liabilities of the group as of June 30, 2023, amounted to HKD 39,324,000, down from HKD 44,412,000 as of December 31, 2022[193]. - The total equity attributable to equity holders of the company was HKD 107.8 million as of June 30, 2023, down from HKD 111.2 million at the end of 2022[51]. - Cash and cash equivalents decreased to HKD 71.9 million as of June 30, 2023, from HKD 85.7 million at the end of 2022[51]. - Financial liabilities, including accounts payable and other payables, totaled HKD 35,939 thousand, down from HKD 39,987 thousand at the end of 2022[72]. Fair Value and Investments - The group recorded a fair value gain of approximately HKD 7,551,000 for financial assets measured at fair value through profit or loss, compared to a fair value loss of approximately HKD 18,213,000 for the six months ended June 30, 2022[2]. - The investment in Mobvoi had a fair value of approximately HKD 32,752,000, representing about 22.7% of the group's total assets as of June 30, 2023[7]. - The group confirmed a fair value gain of approximately HKD 7,551,000 during the period from its investment in Mobvoi[7]. - The fair value of the investment in Mobvoi increased by approximately 30% to about HKD 32,752,000 as of June 30, 2023, compared to approximately HKD 25,201,000 as of December 31, 2022[197]. Expenses - General and administrative expenses for the period were approximately HKD 11,305,000, a decrease of about 19% compared to approximately HKD 13,992,000 for the six months ended June 30, 2022[1]. - Distribution and selling expenses for the period were approximately HKD 10,446,000, a decrease of about 25% from approximately HKD 14,001,000 for the six months ended June 30, 2022[134]. - The company’s research and development expenses for the six months ended June 30, 2023, were HKD 469, a slight decrease from HKD 527 in the same period of 2022[50]. - Financial expenses for the six months ended June 30, 2023, totaled HKD 165 thousand, a decrease of 21.0% from HKD 209 thousand in the previous year[103]. Cash Flow - For the six months ended June 30, 2023, the net cash used in operating activities was HKD (11,102) thousand, an improvement from HKD (13,619) thousand in the same period of 2022[53]. - The net cash generated from investing activities was HKD 100 thousand, compared to HKD 15 thousand in the previous year, indicating a significant increase[53]. - The net cash used in financing activities was HKD (2,457) thousand, slightly higher than HKD (2,415) thousand in the prior year[53]. - The cash and cash equivalents decreased by HKD 13,459 thousand, compared to a decrease of HKD 16,019 thousand in the same period last year[53]. Corporate Governance - The group has established an audit committee consisting of three independent non-executive directors, ensuring compliance with corporate governance codes[189]. - The company has adopted a code of conduct regarding securities trading by directors, ensuring compliance with GEM Listing Rules[161]. - The company confirmed that all directors complied with the trading standards and code of conduct during the reporting period[161]. Strategic Initiatives - The company aims to diversify into health-related products to mitigate adverse impacts from individual product performance, capitalizing on ongoing demand in the post-pandemic era[131]. - The company plans to continue exploring opportunities with new suppliers and customers across various sectors to create greater value for shareholders[131]. - The group continues to engage in trading, development, and sales of display panels and optical products, indicating ongoing market expansion efforts[69]. Employee Information - The total number of employees increased to 67 from 65, with total employee costs for the period amounting to approximately HKD 12,379,000[156]. - The company’s short-term employee benefits decreased to HKD 3,863 for the six months ended June 30, 2023, from HKD 4,431 in the same period of 2022[113].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Perfect Optronics Limited 圓 美 光 電 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8311） 截至二零二三年六月三十日止六個月 中期業績公告 香港聯合交易所有限公司（「聯交所」）GEM（「GEM」）的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所主板 上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並 應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交所主板買賣 之證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市 場。 本公告的資料乃遵照《香港聯合交易所有限公司的GEM證券上巿規則》（「GEM上市規則」） 而刊載，旨在提供有關圓美光電有限公司（「本公司」）的資料；本公司董事（「董事」）願就 ...

Financial Performance - For the three months ended March 31, 2023, the group recorded revenue of approximately HKD 36.8 million, a decrease of 74.5% compared to HKD 144.1 million for the same period in 2022[6]. - The loss attributable to equity holders of the company for the three months ended March 31, 2023, was approximately HKD 4.7 million, compared to a profit of HKD 23.1 million for the same period in 2022[6]. - The gross profit for the three months ended March 31, 2023, was HKD 6.2 million, down from HKD 42.2 million in the same period of 2022, reflecting a significant decline in sales[7]. - Operating loss for the three months ended March 31, 2023, was HKD 4.9 million, compared to an operating profit of HKD 26.2 million in the same period of 2022[7]. - The total comprehensive loss for the period attributable to equity holders was HKD 4.8 million, compared to a total comprehensive income of HKD 23.1 million for the same period in 2022[16]. - The company's revenue for the three months ended March 31, 2023, was approximately HKD 36,734,000, a decrease of about 75% compared to HKD 144,125,000 for the same period in 2022[83]. - The loss attributable to equity holders for the period was approximately HKD 4,685,000, compared to a profit of HKD 23,093,000 for the same period in 2022[67]. - The basic and diluted loss per share for the three months ended March 31, 2023, was HKD 0.32, compared to earnings of HKD 1.56 per share in the same period of 2022[16]. Sales and Revenue Breakdown - Sales of TFT-LCD panels and modules amounted to approximately HKD 25,994,000, a decrease of about 65% from HKD 73,569,000 in the same period last year[69]. - Sales of health-related products were approximately HKD 6,856,000, down about 88% from HKD 55,029,000 in the same period last year[70]. - Revenue from electronic advertising boards, including digital information displays, electronic shelf displays, and electronic whiteboards, increased by approximately 37%, rising from about HKD 2,521,000 in the previous year to approximately HKD 3,460,000[101]. Expenses and Cost Management - The company's general and administrative expenses for the period were approximately HKD 5,627,000, a reduction of about 22% from HKD 7,232,000 for the same period in 2022[73]. - Distribution and selling expenses decreased by approximately 47%, from about HKD 9,371,000 in the previous year to approximately HKD 4,993,000, primarily due to reduced sales and lower commission, transportation, and promotion costs related to health-related products[104]. - Research and development expenses for the period were approximately HKD 219,000, a decrease of about 13% from HKD 253,000 in the same period last year[89]. Corporate Governance and Management - The board of directors did not declare an interim dividend for the three months ended March 31, 2023, consistent with the previous year[6]. - The company has complied with all provisions of the corporate governance code during the reporting period[55]. - The board of directors and key executives hold a total of 62.39% of the company's issued shares as of March 31, 2023[39]. - The chairman and CEO have suspended their positions pending the outcome of legal proceedings[116]. - An independent non-executive director has been appointed as acting chairman to replace the suspended chairman[116]. Market Outlook and Strategy - The company plans to continue expanding its health-related product offerings to meet consumer demand[86]. - The company anticipates ongoing challenges in the display panel market due to economic uncertainties[71]. - The company continues to monitor the performance of its health-related products and TFT-LCD panels, which have seen a decline in sales[107]. - The company has not disclosed any new product developments or market expansion strategies during this reporting period[25]. - The company has no plans for market expansion or new product development mentioned in the current report[100]. Financial Assets and Investments - The fair value of financial assets measured at fair value through profit or loss as of March 31, 2023, is approximately HKD 24,687,000, a decrease from HKD 25,201,000 as of December 31, 2022, representing a decline of 2.03%[30]. - The fair value change of financial assets measured at fair value through profit or loss for the three months ended March 31, 2023, resulted in a loss of HKD 514, compared to a gain of HKD 913 for the same period in 2022[61]. - The net foreign exchange gain for the three months ended March 31, 2023, was HKD 183, compared to a loss of HKD 43 for the same period in 2022[61]. - The company's ownership in Mobvoi Inc. remains at approximately 1.57% as of March 31, 2023, unchanged since the investment in January 2015[30]. - The fair value of the company's investment in Mobvoi's preferred shares was approximately HKD 24,687,000 as of March 31, 2023, a slight decrease of about 2% from approximately HKD 25,201,000 at the end of 2022[102]. Shareholder Actions and Stock Options - The company did not redeem any shares during the period, nor did it or any of its subsidiaries purchase or sell any shares of the company[93]. - The company has not issued any stock options since the adoption of the share option scheme[43]. - The company has not established any arrangements for directors to benefit from purchasing shares or bonds of the company or any other corporate entity during the period[112]. - The company has adopted a code of conduct regarding securities trading by directors, which aligns with the trading standards set out in the GEM Listing Rules[113]. - The average number of issued ordinary shares was 1,483,687,000 for both periods[67].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Perfect Optronics Limited 圓 美 光 電 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8311） 截至二零二三年三月三十一日止三個月 第一季度業績公告 香港聯合交易所有限公司（「聯交所」）GEM（「GEM」）的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所主板 上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並 應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交所主板買賣 之證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市 場。 本公告的資料乃遵照《香港聯合交易所有限公司的GEM證券上巿規則》（「GEM上市規則」） 而刊載，旨在提供有關圓美光電有限公司（「本公司」）的資料；本公司董事（「董事」）願就 ...

Corporate Governance - The audit committee held a total of 4 meetings during the year, with all members attending all meetings[1]. - The remuneration committee conducted 3 meetings to review the remuneration policy and assess the performance of executive directors[7]. - The company has established a remuneration policy that includes annual adjustments based on directors' experience and responsibilities[14]. - The nomination committee held 1 meeting to discuss board structure and the re-election of directors[18]. - The audit committee reviewed the effectiveness of the company's internal control and risk management systems[24]. - The company ensures compliance with GEM Listing Rules and has provided training records for directors during the year[10]. - The remuneration committee did not recommend any changes to the existing remuneration policy and structure[7]. - The company has adopted incentive bonus schemes to align the financial well-being of the group with that of employees[14]. - The audit committee assists the board in providing an independent view of the company's financial reporting process[24]. - The company has arranged appropriate liability insurance for directors and senior management, reviewed annually[28]. - The company's board meetings were attended by all executive and independent non-executive directors, with a perfect attendance record of 4/4 for each member[32]. - The remuneration policy for directors is based on their experience, responsibilities, workload, and time dedicated to the group, with adjustments made annually by the remuneration committee[33]. - The nomination committee, consisting of three independent non-executive directors, held one meeting during the year to review the board's structure and diversity policy[35][36]. - The nomination policy includes criteria such as character, qualifications, willingness to devote time, and adherence to independence guidelines as per GEM Listing Rules[40][42]. - Directors are subject to retirement by rotation at least once every three years, with eligibility for re-election at each annual general meeting[45]. Financial Performance - Perfect Optronics Limited reported its annual results for the year ended December 31, 2022[64]. - The Group's revenue decreased from approximately HK$528.4 million in 2021 to approximately HK$301.3 million in 2022, representing a 43% decline[65]. - Sales of thin film transistor liquid crystal display (TFT-LCD) panels and modules amounted to approximately HK$155.9 million, a 64% decrease compared to 2021[66]. - Sales of polarisers decreased by 19% to approximately HK$36.6 million compared to 2021[66]. - Despite the overall revenue drop, sales of electronic signage products increased by 7% to approximately HK$16.4 million, driven by the Taiwan market[67]. - The Group recorded a consolidated profit attributable to equity holders of approximately HK$4.0 million in 2022, compared to a consolidated loss of approximately HK$43.9 million in 2021[65]. - The fair value of the Group's investment in Mobvoi Inc. decreased to approximately HK$25.2 million, with a fair value loss of approximately HK$13.3 million recognized during the year[72]. - Sales of health-related products increased significantly from approximately HK$19.2 million in 2021 to approximately HK$87.9 million in 2022, becoming a key revenue driver[99]. - The Group's sales of electronic advertising boards reached approximately HK$16.4 million, an increase of 7% compared to 2021[98]. - The decline in demand for display products was attributed to global economic recession expectations and oversupply in the market[114]. - The introduction of the "K-clean" brand and rapid antigen test kits significantly contributed to the Group's revenue growth in health-related products[119]. - The Group's flexible business strategies, including the diversification into health-related products, were key to the turnaround from loss to profit[121]. Risk Management - The Group's financial activities are exposed to various risks, including market risk, credit risk, and liquidity risk[165]. - A slowdown in the global economy may lead to decreased market demand, putting downward pressure on average selling prices and negatively impacting the Group's business[162][167]. - The Group's risk management framework ensures risks are effectively controlled in line with its risk tolerance[132]. - The audit committee has requested management to follow up on the recommendations made by the external consultant to address identified control issues[133]. - The Company has implemented a material transactions authorization policy, which includes additional authorization procedures and monthly reporting for transactions above certain thresholds[137]. - The Board concluded that the Group's risk management and internal control systems were effective and adequate, with annual reviews planned[138]. - The Group engaged CT Partners Consultants Limited to conduct a review of the effectiveness of its risk management and internal control systems, which included recommendations for improvement[129]. Shareholder Communication - The Company aims to provide high standards of disclosure and financial transparency to its shareholders and investors[144]. - The Board reviewed the effectiveness of the shareholders' communication policy, confirming its effectiveness in enhancing communication[147]. - The management emphasizes the importance of maintaining high levels of disclosure and financial transparency to shareholders and investors[177]. - The Company aims to enhance communication with shareholders through regular reports and meetings, ensuring timely and accurate information dissemination[177]. Strategic Direction - The Group aims to diversify its business and explore potential opportunities in various markets to enhance competitiveness[105]. - The Group plans to introduce more health care products to meet consumer demand and expand its health-related products business[105]. - The Group will continue to explore opportunities with new suppliers and customers from various industries to create greater value for the Company and its shareholders[156][159]. - The Group plans to widen its product diversity in the health-related products market to minimize adverse impacts from individual products[156][159].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Perfect Optronics Limited 圓 美 光 電 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8311） 截至二零二二年十二月三十一日止年度業績公告 香港聯合交易所有限公司（「聯交所」）GEM（「GEM」）的特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在聯交所主板 上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風險，並 應經過審慎周詳的考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交所主板 買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的 市場。 本公告的資料乃遵照《香港聯合交易所有限公司的GEM證券上巿規則》（「GEM上市規則」） 而刊載，旨在提供有關圓美光電有限公司（「本公司」）的資料；本公司董事（「董事」）願就 本公告的資料共同及個別地承 ...

[Report Summary](index=3&type=section&id=Report%20Summary) The Group successfully turned a loss into a profit for the nine months ended September 30, 2022, with a profit attributable to equity holders of approximately HKD 6.2 million, despite a decrease in revenue Key Performance for the Nine Months Ended September 30, 2022 | Indicator | Nine Months Ended September 30, 2022 | Nine Months Ended September 30, 2021 | | :--- | :--- | :--- | | Revenue | Approx. HKD 257.3 million | Approx. HKD 377.5 million | | Profit / (Loss) Attributable to Equity Holders | Profit approx. HKD 6.2 million | Loss approx. HKD 39.7 million | - The Board does not recommend an interim dividend for the nine months ended September 30, 2022[4](index=4&type=chunk) [Financial Results](index=4&type=section&id=Financial%20Results) This section presents the unaudited condensed consolidated financial statements, including the statement of comprehensive income, statement of changes in equity, and detailed notes on revenue composition, other gains/losses, interim dividends, and earnings per share calculations [Unaudited Condensed Consolidated Statement of Comprehensive Income](index=4&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Comprehensive%20Income) During the reporting period, the Group's revenue decreased year-on-year, but it successfully turned a loss into a profit, with a significant improvement in gross profit, resulting in a profit attributable to equity holders of HKD 6.2 million for the nine months ended September 30, 2022, compared to a loss of HKD 39.68 million in the prior year, and basic earnings per share of 0.42 HK cents Key Data from Consolidated Statement of Comprehensive Income (Nine Months Ended September 30, HKD Thousands) | Indicator (HKD Thousands) | 2022 (Unaudited) | 2021 (Unaudited) | | :--- | :--- | :--- | | Revenue | 257,337 | 377,462 | | Gross Profit | 60,762 | 11,420 | | Operating Profit / (Loss) | 9,269 | (39,940) | | Profit / (Loss) for the Period | 5,251 | (40,297) | | Profit / (Loss) Attributable to Equity Holders | 6,198 | (39,676) | | Basic Earnings / (Loss) Per Share (HK cents) | 0.42 | (2.67) | [Unaudited Condensed Consolidated Statement of Changes in Equity](index=6&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Changes%20in%20Equity) This statement details the changes in the Group's equity items, including share capital, share premium, various reserves, and retained earnings, for the nine months ended September 30, 2022 - The report includes the unaudited condensed consolidated statement of changes in equity for the nine months ended September 30, 2022, reflecting changes in share capital, reserves, and retained earnings[10](index=10&type=chunk) [Notes to the Unaudited Condensed Consolidated Financial Results](index=7&type=section&id=Notes%20to%20the%20Unaudited%20Condensed%20Consolidated%20Financial%20Results) The financial notes provide supplementary information to the financial statements, including revenue breakdown by product category, composition of other gains and losses (primarily fair value changes of financial assets), taxation, and the basis for earnings per share calculation, indicating significant growth in health-related product revenue and a decline in traditional display product revenue [Revenue Composition](index=8&type=section&id=3.%20Revenue) The Group's total revenue is primarily derived from display products and health-related products, with TFT-LCD panel and module revenue decreasing by 55% year-on-year in the first nine months of 2022, while health-related product revenue significantly increased by nearly four times, becoming a crucial revenue source Revenue by Product Category (Nine Months Ended September 30, HKD Thousands) | Product Category | 2022 (Unaudited) | 2021 (Unaudited) | | :--- | :--- | :--- | | TFT-LCD Panels and Modules | 135,210 | 297,644 | | Health-Related Products | 76,318 | 15,628 | | Polarizers | 35,864 | 37,683 | | Electronic Billboards | 5,687 | 11,697 | | Integrated Circuits | 1,829 | 6,291 | | **Total** | **257,337** | **377,462** | [Net Other Gains / (Losses)](index=8&type=section&id=4.%20Net%20Other%20Gains%20%2F%20(Losses)) Net other losses of approximately HKD 12.3 million were recorded during the period, primarily due to a fair value loss of approximately HKD 12.58 million from the equity investment in Mobvoi Inc., which is a narrower loss compared to HKD 19.25 million in the prior year - Fair value loss on financial assets at fair value through profit or loss was **HKD 12.581 million** during the period, primarily from the investment in private company Mobvoi Inc[19](index=19&type=chunk)[21](index=21&type=chunk) - The fair value of the investment in Mobvoi decreased from approximately **HKD 38.46 million** at the end of 2021 to approximately **HKD 25.88 million** as of September 30, 2022[21](index=21&type=chunk) [Interim Dividend](index=10&type=section&id=7.%20Interim%20Dividend) The Board did not declare an interim dividend for the nine months ended September 30, 2022 - The Board did not declare an interim dividend for the nine months ended September 30, 2022, consistent with the prior year period[26](index=26&type=chunk) [Basic and Diluted Earnings / (Loss) Per Share](index=10&type=section&id=8.%20Basic%20and%20Diluted%20Earnings%20%2F%20(Loss)%20Per%20Share) Based on a profit attributable to equity holders of HKD 6.2 million, basic and diluted earnings per share were calculated at 0.42 HK cents, compared to a loss per share of 2.67 HK cents in the prior year period Earnings Per Share Calculation | Indicator | Nine Months Ended September 30, 2022 | Nine Months Ended September 30, 2021 | | :--- | :--- | :--- | | Profit / (Loss) Attributable to Equity Holders (HKD Thousands) | 6,198 | (39,676) | | Weighted Average Number of Ordinary Shares in Issue (Thousands of Shares) | 1,483,687 | 1,483,687 | | Basic and Diluted Earnings / (Loss) Per Share (HK cents) | 0.42 | (2.67) | [Management Discussion and Analysis](index=11&type=section&id=Management%20Discussion%20and%20Analysis) This section provides an overview of the Group's business performance and financial position, highlighting key drivers for the turnaround to profitability, challenges faced in the display market, and the impact of investment fair value changes [Business Review and Outlook](index=11&type=section&id=Business%20Review%20and%20Outlook) Despite weakened demand in the display panel market due to international conflicts and high inflation, leading to a 32% year-on-year decrease in total revenue to HKD 257 million, the Group successfully turned a loss into a profit of HKD 6.2 million, driven by strong growth and higher gross margins in health-related products, while the investment in Mobvoi recorded a fair value loss due to capital market deterioration, with the Group aiming to continue seizing market opportunities and diversifying products for future value creation - Despite a year-on-year revenue decrease of approximately **32%**, the Group successfully turned a loss into a profit during the period, recording a profit attributable to equity holders of approximately **HKD 6.2 million**, compared to a loss of approximately **HKD 39.7 million** in the prior year period[30](index=30&type=chunk) - Sales of TFT-LCD panels and modules decreased by approximately **55%** year-on-year due to reduced demand for remote work and learning post-pandemic[31](index=31&type=chunk) - Strong sales in health-related products business, including K-clean and rapid antigen test kits, reached **HKD 76.32 million**, a significant year-on-year increase, serving as a primary factor for the Group's turnaround to profitability[34](index=34&type=chunk) - The investment in AI company Mobvoi recognized a fair value loss of approximately **HKD 12.58 million** during the period[37](index=37&type=chunk) [Financial Review](index=14&type=section&id=Financial%20Review) The core of this period's financial performance is 'increased profit without increased revenue,' with total revenue decreasing by 32% due to declining display product sales, but gross profit surging to HKD 60.76 million (compared to HKD 11.42 million in the prior year) driven by a significant increase in high-margin health-related product sales, while distribution and selling expenses rose by 46% due to health product business expansion, ultimately leading to a successful turnaround to profitability thanks to substantial gross profit improvement and reduced fair value losses on financial assets - Gross profit significantly increased to approximately **HKD 60.76 million**, primarily due to revenue growth from high-margin health-related products[41](index=41&type=chunk) - Distribution and selling expenses increased by approximately **46%**, mainly due to higher sales commissions, staff costs, and promotional expenses generated by health-related products[43](index=43&type=chunk) - The turnaround to profitability is primarily attributable to a substantial increase in profit from health-related products and a reduction in fair value losses on financial assets at fair value through profit or loss[46](index=46&type=chunk) [Other Disclosures](index=15&type=section&id=Other%20Disclosures) This section provides details on directors' and substantial shareholders' interests, the share option scheme, and other compliance matters, including a non-competition undertaking and ongoing legal proceedings initiated by the Hong Kong SFC [Directors' and Chief Executive's Interests and Short Positions](index=15&type=section&id=Directors'%20and%20Chief%20Executive's%20Interests%20and%20Short%20Positions%20in%20Shares%2C%20Underlying%20Shares%20and%20Debentures%20of%20the%20Company%20or%20any%20Associated%20Corporation) As of September 30, 2022, Mr. Cheng Wai Tak, a Director, held a combined 62.39% equity interest in the Company through his wholly-owned company, Winful Enterprises Limited, and personal beneficial ownership Directors' Shareholdings | Director Name | Capacity | Number of Shares Held | Equity Percentage | | :--- | :--- | :--- | :--- | | Mr. Cheng Wai Tak | Interest of controlled corporation and beneficial owner | 925,647,151 | 62.39% | | Mr. Kan Man Wai | Beneficial owner | 320,000 | 0.02% | [Substantial Shareholders' Interests and Short Positions](index=16&type=section&id=Substantial%20Shareholders'%20Interests%20and%20Short%20Positions%20in%20Shares%20and%20Underlying%20Shares%20of%20the%20Company) As of September 30, 2022, Winful Enterprises Limited, as a substantial shareholder, directly and beneficially owned **62.24%** of the Company's shares - Substantial shareholder Winful Enterprises Limited directly holds **923,427,151** shares of the Company, representing **62.24%** of the issued shares, and is wholly owned by Director Mr. Cheng Wai Tak[53](index=53&type=chunk)[54](index=54&type=chunk) [Share Option Scheme](index=16&type=section&id=Share%20Option%20Scheme) The Company adopted a share option scheme in January 2014, but no share options have been granted under the scheme since its adoption - No share options have been granted by the Company since the adoption date of the share option scheme[56](index=56&type=chunk) [Other Compliance Disclosures](index=17&type=section&id=Other%20Compliance%20Disclosures) This section covers various compliance matters, including a non-competition undertaking by the controlling shareholder, and discloses legal proceedings initiated by the Hong Kong SFC against the Company and certain directors alleging breach of duties, with the relevant directors having suspended their roles pending the outcome of the legal proceedings - Controlling shareholder Mr. Cheng Wai Tak and Winful Enterprises have provided a non-competition undertaking to the Company[61](index=61&type=chunk) - The Hong Kong Securities and Futures Commission has filed a petition against the Company and certain directors under Section 214 of the Securities and Futures Ordinance, alleging breach of duties by directors concerning a subsidiary disposal matter[65](index=65&type=chunk) - The petitioned directors have suspended their directorships since September 25, 2020, pending the conclusion of the legal proceedings[66](index=66&type=chunk) [Corporate Governance](index=19&type=section&id=Corporate%20Governance) This section outlines the Company's adherence to corporate governance principles, specifically detailing the composition and responsibilities of the Audit Committee [Audit Committee](index=19&type=section&id=Audit%20Committee) The Company has established an Audit Committee, comprising three independent non-executive directors, in compliance with the Corporate Governance Code, and this committee has reviewed the quarterly report - The Company has complied with all code provisions of the Corporate Governance Code[68](index=68&type=chunk) - The Audit Committee is composed of three independent non-executive directors and has reviewed this quarterly report[69](index=69&type=chunk)

Financial Performance - For the six months ended June 30, 2022, the group recorded revenue of approximately HKD 209.9 million, a decrease of 9.5% compared to HKD 231.2 million for the same period in 2021[4] - The profit attributable to equity holders for the six months ended June 30, 2022, was approximately HKD 2.5 million, a turnaround from a loss of HKD 3.0 million for the same period in 2021[4] - The gross profit for the six months ended June 30, 2022, was HKD 52.2 million, compared to HKD 17.7 million for the same period in 2021, indicating a significant improvement[6] - The operating profit for the six months ended June 30, 2022, was HKD 5.6 million, compared to an operating loss of HKD 3.2 million for the same period in 2021[6] - The basic and diluted earnings per share for the six months ended June 30, 2022, were HKD 0.17, compared to a loss of HKD 0.20 for the same period in 2021[8] - The company reported a net loss attributable to equity holders of HKD 2,515 thousand for the six months ended June 30, 2022, compared to a loss of HKD 3,032 thousand in the same period of 2021[57] - Basic and diluted loss per share improved to HKD 0.17 from HKD 0.20 year-on-year[57] - The company reported a profit attributable to equity holders of approximately HKD 2,515,000, a turnaround from a loss of approximately HKD 3,032,000 in the same period last year[85] Revenue Breakdown - Revenue for the six months ended June 30, 2022, was HKD 209,854 thousand, a decrease of 9.2% from HKD 231,168 thousand in the same period of 2021[44] - Revenue from health-related products significantly increased to HKD 66,191 thousand, up from HKD 12,182 thousand, representing a growth of 442%[44] - Revenue from major customers (each contributing 10% or more to total revenue) totaled HKD 58,941 thousand, down from HKD 85,523 thousand, a decline of 31.1%[47] - Sales of TFT-LCD panels and modules amounted to approximately HKD 110.067 million, a decrease of about 37% from approximately HKD 174.217 million in the same period last year[71] - Sales of polarizer products increased by approximately 8% to HKD 25.825 million, compared to HKD 23.930 million in the same period last year[71] - Revenue from electronic advertising board products was approximately HKD 3.989 million, a decrease of about 49% from approximately HKD 7.793 million in the same period last year[72] Assets and Liabilities - Total assets as of June 30, 2022, amounted to HKD 150.95 million, a decrease from HKD 195.75 million as of December 31, 2021[10] - The company's cash and cash equivalents as of June 30, 2022, were HKD 71.9 million, down from HKD 88.5 million as of December 31, 2021[10] - Inventory as of June 30, 2022, was HKD 24.6 million, significantly reduced from HKD 43.1 million as of December 31, 2021[10] - Total liabilities decreased from HKD 89,891 thousand as of December 31, 2021, to HKD 43,221 thousand as of June 30, 2022, representing a reduction of approximately 52.1%[12] - Total equity attributable to equity holders as of June 30, 2022, was HKD 109.7 million, an increase from HKD 107.3 million as of December 31, 2021[10] - Total financial expenses decreased to HKD 209 thousand from HKD 246 thousand year-on-year[50] - The company's accounts receivable increased to HKD 17.885 million as of June 30, 2022, compared to HKD 7.758 million as of December 31, 2021[64] - Total liabilities decreased to HKD 30.307 million as of June 30, 2022, from HKD 78.358 million as of December 31, 2021[64] Cash Flow and Investments - Net cash used in operating activities was HKD (13,619) thousand for the six months ended June 30, 2022, compared to HKD 7,733 thousand generated in the same period of 2021[17] - The company reported a net cash outflow of HKD 16,019 thousand for the six months ended June 30, 2022, compared to a net inflow of HKD 5,161 thousand in the same period of 2021[17] - The company held financial assets at fair value through profit or loss amounting to HKD 20,248 thousand as of June 30, 2022, down from HKD 38,461 thousand as of December 31, 2021, a decrease of approximately 47.5%[25] - The group recognized a fair value loss of approximately HKD 18,213,000 on the investment in Mobvoi for the six months ended June 30, 2022[101] Operational Challenges and Future Outlook - The company’s management reported that the ongoing COVID-19 pandemic and inflation continue to pose challenges to the global economy[70] - Future market outlook indicates challenges in the display panel market due to high inflation and uncertainties from the COVID-19 pandemic, but the company aims to seize market opportunities[77] - The company plans to continue developing the electronic advertising board market and expand into overseas markets[72] - The company plans to continue strategic deployment in health-related products and broaden product diversity to mitigate adverse impacts from individual products[77] Corporate Governance - The company has adopted a set of securities trading code of conduct for directors, which aligns with the GEM Listing Rules[119] - The company has complied with all provisions of the corporate governance code during the six months ending June 30, 2022[127] - The company has established an audit committee consisting of three independent non-executive directors[129] - There were no competitive interests held by directors or controlling shareholders during the six months ending June 30, 2022[123] - The company has confirmed that all directors have complied with the trading standards and code of conduct during the reporting period[119]